Growing awareness on animal health will drive the demand for veterinary vaccines in the coming years

Veterinary vaccines help in improving animal health, increase production of livestock in a cost effective manner and prevent transmission of diseases among animals. The veterinary vaccines market has witnessed significant growth over the past few years, due to fear of impending pandemics that have led to heavy losses particularly in poultry. The global veterinary vaccines market is driven by factors such as the vulnerability of animals to fatal and chronic diseases, and rapidly changing patterns of diseases among animals. Veterinary vaccines have also reduced the amount of drug treatments to control established diseases and, in many instances, have prevented long term suffering and death. The global veterinary vaccines market has undergone considerable progress during the past few years with the increasing use of continuous cell lines as a substrate and adoption of the fermentor technology for antigen production. These vaccines are produced for administration by parenteral or oral routes depending on the vaccine characteristics.

The global animal vaccines market has been broadly classified as companion and livestock vaccines. The companion animal vaccines segment has been further categorized into canine and feline vaccines. The canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment in 2013, due to higher average cost associated with canine vaccination. The livestock vaccines segment has been sub-segmented into five major categories: porcine, bovine, ovine, poultry and equine. Of these, the bovine vaccines sub-segment accounted for the largest share (in terms of revenue) in 2013, followed by porcine.

Among the four major geographies namely North America, Europe, Asia-Pacific and Rest of the world, European region is known to be a leading veterinary vaccine market in terms of consumption, closely followed by the U.S. These two regions collectively account for more than 70% of the global veterinary vaccine market revenue. Growing demand for the vaccines from Asia, Latin America and Eastern European countries and increased vulnerability of animals to fatal and chronic diseases is steering the demand for veterinary vaccines. The manufacturers are investing heavily in new product developments due to rapidly changing patterns of the diseases and increased resistance to the currently used vaccines. Growing awareness on animal health with early disease detection and preventive medicines will drive the demand for veterinary vaccines in the coming years. Technological advancements such as introduction of DNA vaccines and other products will ensure greater production and immune responses than the conventional vaccines. Increased demand for animal protein, including milk, meat, eggs and fish, increased expenditure on healthcare of companion animals, are the major factors expected to boost the growth of the global veterinary vaccines market.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=215

Increasing awareness against the use of antimicrobials is encouraging the vaccine producers to invest significantly into development of new products. Many of the established bacterial vaccines are highly efficacious. Certain vaccines such as live and inactivated bacterial vaccines are also produced by local veterinary institutions or specialized companies for on-farm specific demands where no commercial vaccines are available.

Sanofi Animal Health, Bayer HealthCare AG, Bioniche Animal Health Canada, Inc., Biogenesis Bago SA, Heska Corporation, Boehringer Ingelheim GmbH, Indian Immunologicals Ltd. Novartis Animal Heath, Inc., Merck & Co. Inc, Zoetis, and Protein Sciences Corporation are the leading players in the global veterinary vaccine market. Other players include Imugene Limited, Lohmann Animal Health, Merck & Co. Inc., Embrex Inc., Intervet/Schering-Plough Animal Health, Fort Dodge Animal Health, Pfizer, Inc. and Virbac Corporation.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.